Cell & Gene Therapies Annual Meeting

Cell & Gene therapies are the latest revolution in medicine manufacturing. Unlike small molecules or traditional biotech products, these therapies introduce cells and genes into a patient to treat the underlying cause of a disease—they are living medicines!

Whether you are producing biologic drug substance, conducting sterile fill-finish operations, or entering into cell and gene therapy, this meeting will provide the latest information to help your organization have the knowledge and agility needed to meet the needs of the patients we serve.

Our esteemed speakers will share their experience and recent advancements on Cell & Gene Therapies, with insights from clinical trials to manufacturing and commercialization aspects of the drugs of the future.

Join this interactive session, in the heart of the San Francisco Biotech Valley, to connect with key players, learning their latest strategies, challenges and vision for the future of Cell & Gene Therapies.

Speakers selection in progress, if you or your company is interested to be part of it send us a note at

Confirmed Panelists:

Jeff Ajer joined BioMarin in August 2005 and currently serves as our Executive Vice President and Chief Commercial Officer. From October 2012 to January 2014, Mr. Ajer served as our Senior Vice President and Chief Commercial Officer.

From April 2009 to October 2012, Mr. Ajer served as our Vice President, Commercial Operations, The Americas, where he had responsibility for commercial operations throughout the Americas and led product marketing, reimbursement, and sales operations for BioMarin.

Prior to joining BioMarin, Mr. Ajer served in various roles at Genzyme Corporation (Genzyme) beginning in November 2003, most recently as Vice President, Global Transplant Operations from December 2004 to August 2005. Mr. Ajer’s experience prior to Genzyme includes roles in sales, marketing and operations at SangStat Medical Corporation and ICN Pharmaceuticals.

Mr. Ajer received both a B.S. in chemistry and an M.B.A. from the University of California, Irvine.

Mr. Ajer is currently a director of Nektar Therapeutics, a public biopharmaceutical company.

Maik W. Jornitz, President and CEO of G-CON Manufacturing Inc., is a technical expert with over 30 years of experience in bioprocesses, especially sterilizing grade filtration and single-use technologies, including regulatory requirements, integrity testing, systems design, and optimization.

Jornitz has published 11 books, 18 book chapters and over 100 scientific papers. He is the former Chair of the PDA Board of Directors and Science Advisory Board, and member of multiple PDA Task Forces. He is working member of BPOG, ASTM, an advisory board member of the Biotechnology Industry Council, ICAV and multiple science journals.

He recently has been recognized as one of the top ten global industry influencers. As a faculty member of various training activities, including PDA TRI, he trains members of the industry and regulatory authorities on a frequent basis.

He received his M.Eng. in Bioengineering at the University of Applied Sciences in Hamburg, Germany and accomplished the PED program at IMD Business School in Lausanne, Switzerland.

Agenda:

5:30 PM Registration/Networking/Complementary Buffet Dinner & Beverages

6:45 PM Announcements

7:30 PM Panel Discussion

9:00 PM Closing

FAQs

How can I contact the organizer with any questions?

You can contact the event organizer sending an email to [email protected], please allows few days for the response, emails will not be monitored on the day of the event.

Is my registration fee or ticket transferable?

Ticket is not reimbursable, however you can transfer it by 12FEB21 to whoever would like to attend in your behalf

My company would like to become a WCC PDA Sponsor, do you have a sponsorship program?

Yes, our offers a unique opportunity for companies that want to strengthen brand image, increase visibility, and gain access to leaders of the San Francisco Bay Life-Science Community

What is the dressing code?

Business casual

Cancellation Policy:

Dinner seating is confirmed and reserved in advance. We regret that no refunds can be offered for non-attendance. If a registrant cannot attend, substitutions are welcome by 12APR20. The chapter reserves the right to cancel a dinner meeting if the minimum number of attendees is not met by Monday prior to the event. The chapter reserves the right to not answer emails or phone calls on the day of the event

Privacy Policy:

We manage your personal data responsibly and align with PDA privacy policy.

REGISTRATION AGREEMENT: by registering to this event I consent the WCC PDA to record and/or photograph me and using those recording and/or photographs in the future WCC PDA promotional and marketing material, and to send me promotional information via email.

Host or Publisher Parenteral Drug Association West Coast Chapter